SWOG clinical trial number
SWOG-9401 (NCCTG-90-46-52)
A Controlled Phase III Evaluation of 5-FU Combined with Levamisole and Leucovorin as Surgical Adjuvant Treatment Following Total Gross Resection of Metastatic Colorectal Cancer
Closed
Phase
Published
Abbreviated Title
A Controlled Phase III Evaluation of 5-FU Combined with Levamisole and Leucovorin as Surgical Adjuvant Treatment Following Total Gross Resection of Metastatic Colorectal Cancer
Activated
08/15/1994
Closed
09/10/1996
Publication Information Expand/Collapse
2001
Phase III trial of 5-Fluorouracil (5FU), levamisole (LEV), +/- leucovorin (LV) as adjuvant treatment (ADJ) of resected metastatic colorectal cancer (M-CRC) an NCCTG/MD Anderson/SWOG study.
1995
Phase II study of taxol in patients (pts) with recurrent malignant glioma: North American Brain Tumor Consortium